Domnguez-Mozo MI, Garca-Frontini Nieto MC, Gmez-Calcerrada MI, Prez-Prez S, Garca-Martnez M, Villar LM, et al
Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, Lurati FM, et al
The article states it flatly in a table cell with no study, population, or effect size behind it, and prediction is a strong word for an inflammatory marker with no established role in dose selection
Elkind-Hirsch KE, Chappell N, Shaler D et al (2022) Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study
pharmaceutically acceptable excipients may include, but are not limited to, cellulose derivatives, sucrose, and starch